Podcast: Curry chemical on trial, death rates fall, ASCO conference highlights and more

Click on the logo to download the podcast

This month, a new trial looks at the cancer-fighting properties of the curry chemical curcumin, while we take a look at the reasons why cancer deaths in middle age have fallen.

Plus, we hear why it’s important that the new prostate cancer drug abiraterone has been approved by NICE, and highlight a concerning study revealing poorer cancer survival in men with mental illness.

And finally, we bring you our highlights from the recent ASCO Conference in Chicago – the biggest cancer conference in the world.

Listen now through the player below:

Or click here to download the podcast as an mp3.

Also, the podcast is available on iTunes to subscribe and download for free.

Alternatively, go to the podcast page on our website, where you can hear the show directly through our own Flash player and explore previous shows in the archive. And there’s also a full transcript of the podcast available here.

We hope you enjoy it – please do let us know what you think of the podcast in the comments below, or email us at [email protected].

Kat